358 related articles for article (PubMed ID: 6974303)
1. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
Portek I; Graham G; Fleming A
Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
[TBL] [Abstract][Full Text] [Related]
2. Interaction of omeprazole with enteric-coated salicylate tablets.
Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
[TBL] [Abstract][Full Text] [Related]
3. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
5. Single-dose evaluation of a new enteric-coated aspirin preparation.
Paull P; Day R; Graham G; Champion D
Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
[TBL] [Abstract][Full Text] [Related]
7. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
Mielants H; Verbruggen G; Schelstraete K; Veys EM
J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an enteric coated aspirin preparation.
Day RO; Paull PD; Champion GD; Graham GG
Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299
[TBL] [Abstract][Full Text] [Related]
9. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
Canada AT; Little AH; Creighton EL
Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
[No Abstract] [Full Text] [Related]
10. Salicylates in the management of rheumatoid arthritis.
Pinals RS
Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
[No Abstract] [Full Text] [Related]
11. Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin?
Walker J; Robinson J; Stewart J; Jacob S
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):519-22. PubMed ID: 17669925
[TBL] [Abstract][Full Text] [Related]
12. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 4th Part: Influence of the enteric polymer dissolution pH on the "in vivo" absorption of aspirin from coated tablets (author's transl)].
Delporte JP; Jaminet F
J Pharm Belg; 1976; 31(3):263-76. PubMed ID: 8603
[No Abstract] [Full Text] [Related]
13. [Acetylsalicylic acid and gastrointestinal bleeding--a study of blood loss and absorption after intake of a gastric juice--resistant preparation].
Arvidsson B; Magnusson A; Magnusson B; Sölvell L
Lakartidningen; 1977 Nov; 74(46):4101-2. PubMed ID: 337007
[No Abstract] [Full Text] [Related]
14. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
Paton TW; Walker SE; Leung FY; Little AH
Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
[No Abstract] [Full Text] [Related]
15. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
[TBL] [Abstract][Full Text] [Related]
16. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
17. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
Schwertner HA; McGlasson D; Christopher M; Bush AC
Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
[TBL] [Abstract][Full Text] [Related]
18. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].
Laine V; Strandman D; Tikkanen R
Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894
[No Abstract] [Full Text] [Related]
19. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
Bendas ER; Ayres JW
Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
[TBL] [Abstract][Full Text] [Related]
20. Coated aspirin no safer.
Health News; 2000 Dec; 6(12):8. PubMed ID: 11142949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
